Biotech Company
- All
- News
- Videos
-
How Trumps DOGE Co-Head Vivek Ramaswamy Built A Billion-Dollar Empire
Mr Ramaswamy, the 39-year-old biotech investor and "anti-woke" advocate, has built a billion-dollar fortune through his drug-development company, Roivant Sciences, which went public in 2021.
-
"Remarkable Influence": Bharat Biotech Co-Founder Honoured By Johns Hopkins
Dr Krishna Ella, co-founder and Executive Chairman of Bharat Biotech, has been awarded the prestigious Dean's medal by the Johns Hopkins Bloomberg School of Public Health, the Hyderabad-based pharma company said on Friday.
-
World's First Saliva Pregnancy Test Launched In UK
The product named Salistick has been developed by an Israeli biotech company and is based on the technology used to make Covid testing kits.
-
US-Based Indian Develops Software To Build Career Plans Based On Genes
Responding to a question on artificial intelligence, Mr Saidalvi said that it definitely will cut a lot of jobs.
-
After Uzbekistan Syrup Deaths, Regulator's Big Move Against Delhi Firm
India's drug regulator directed drug manufacturers not to use propylene glycol supplied by a Delhi-based company which provided the ingredient to Marion Biotech, whose cough syrups were alleged to have led to the deaths of children in Uzbekistan.
-
3 Lakh Doses Of Intranasal Covid Vaccine Sent To Hospital: Bharat Biotech
Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday.
-
Scientists Plan To Bring Back A Bird That's Been Extinct Since The 17th Century
Researchers may be able to recreate a bird's characteristics in the body of a living relative using cutting-edge gene-editing techniques.
-
India Gets Its Own Nasal Vaccine, Booster Costs Rs 800 Per Dose
The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.
-
"Substandard": WHO Alert On 2 Indian Syrups After Uzbekistan Child Deaths
The World Health Organisation (WHO) has recommended that two cough syrups made by Noida-based company Marion Biotech should not be used for children in Uzbekistan.
-
50 Million Doses Of Covaxin Set To Expire Early 2023: Report
Nearly 50 million doses of Bharat Biotech's COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources said.
-
Twitter Accounts Hyped Company Seeking Covid Vaccine Trials: Report
A network of Twitter accounts pushed messages to boost the share price of a biotech company as it sought approval to run a clinical trial of its Covid-19 vaccine, according to research provided to Bloomberg News.
-
Covid Nasal Vaccine's Phase 3 Trials Completed, Says Bharat Biotech Chief
Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller General of India next month.
-
Moderna's New Bivalent Omicron Jab Shows "Positive Results" In Trials
US biotech company Moderna on Wednesday announced positive results for a new vaccine that targets both the original Covid strain and Omicron.
-
Vaccine Not Sent To UN Bodies, Says Bharat Biotech On WHO Action: Sources
With WHO announcing the suspension of Covaxin supply through UN procurement agencies, Bharat Biotech sources said on Monday the pharma company has not supplied the COVID-19 vaccine to any UN agency and no impact of the suspension would be felt.
-
No Impact Of WHO Action On Covaxin, Have Not Supplied To Any UN Agency: Bharat Biotech
With WHO announcing the suspension of Covaxin supply through UN procurement agencies, Bharat Biotech sources said on Monday the pharma company has not supplied the COVID-19 vaccine to any UN agency and no impact of the suspension would be felt.
-
How Trumps DOGE Co-Head Vivek Ramaswamy Built A Billion-Dollar Empire
Mr Ramaswamy, the 39-year-old biotech investor and "anti-woke" advocate, has built a billion-dollar fortune through his drug-development company, Roivant Sciences, which went public in 2021.
-
"Remarkable Influence": Bharat Biotech Co-Founder Honoured By Johns Hopkins
Dr Krishna Ella, co-founder and Executive Chairman of Bharat Biotech, has been awarded the prestigious Dean's medal by the Johns Hopkins Bloomberg School of Public Health, the Hyderabad-based pharma company said on Friday.
-
World's First Saliva Pregnancy Test Launched In UK
The product named Salistick has been developed by an Israeli biotech company and is based on the technology used to make Covid testing kits.
-
US-Based Indian Develops Software To Build Career Plans Based On Genes
Responding to a question on artificial intelligence, Mr Saidalvi said that it definitely will cut a lot of jobs.
-
After Uzbekistan Syrup Deaths, Regulator's Big Move Against Delhi Firm
India's drug regulator directed drug manufacturers not to use propylene glycol supplied by a Delhi-based company which provided the ingredient to Marion Biotech, whose cough syrups were alleged to have led to the deaths of children in Uzbekistan.
-
3 Lakh Doses Of Intranasal Covid Vaccine Sent To Hospital: Bharat Biotech
Bharat Biotech dispatched three lakh doses of its intranasal COVID-19 vaccine to some hospitals two days ago, the company's executive chairman Krishna Ella said on Sunday.
-
Scientists Plan To Bring Back A Bird That's Been Extinct Since The 17th Century
Researchers may be able to recreate a bird's characteristics in the body of a living relative using cutting-edge gene-editing techniques.
-
India Gets Its Own Nasal Vaccine, Booster Costs Rs 800 Per Dose
The company, in December 2022, got the approval for the primary 2-dose schedule, and as a heterologous booster dose.
-
"Substandard": WHO Alert On 2 Indian Syrups After Uzbekistan Child Deaths
The World Health Organisation (WHO) has recommended that two cough syrups made by Noida-based company Marion Biotech should not be used for children in Uzbekistan.
-
50 Million Doses Of Covaxin Set To Expire Early 2023: Report
Nearly 50 million doses of Bharat Biotech's COVID-19 vaccine, Covaxin lying with the firm are set to expire early next year as there are no takers owing to poor demand, company sources said.
-
Twitter Accounts Hyped Company Seeking Covid Vaccine Trials: Report
A network of Twitter accounts pushed messages to boost the share price of a biotech company as it sought approval to run a clinical trial of its Covid-19 vaccine, according to research provided to Bloomberg News.
-
Covid Nasal Vaccine's Phase 3 Trials Completed, Says Bharat Biotech Chief
Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller General of India next month.
-
Moderna's New Bivalent Omicron Jab Shows "Positive Results" In Trials
US biotech company Moderna on Wednesday announced positive results for a new vaccine that targets both the original Covid strain and Omicron.
-
Vaccine Not Sent To UN Bodies, Says Bharat Biotech On WHO Action: Sources
With WHO announcing the suspension of Covaxin supply through UN procurement agencies, Bharat Biotech sources said on Monday the pharma company has not supplied the COVID-19 vaccine to any UN agency and no impact of the suspension would be felt.
-
No Impact Of WHO Action On Covaxin, Have Not Supplied To Any UN Agency: Bharat Biotech
With WHO announcing the suspension of Covaxin supply through UN procurement agencies, Bharat Biotech sources said on Monday the pharma company has not supplied the COVID-19 vaccine to any UN agency and no impact of the suspension would be felt.
